For founders, CEOs, and growth leads at Series A, B, & C companies where organic growth is a primary acquisition channel.
Organic Growth Diagnostics Methodology
Growth Forensics is the practice that performs Organic Growth Diagnostics, a structured discipline for identifying the specific constraints preventing a company’s organic growth engine from working.
We investigate organic growth systems the way a forensic investigator examines a scene: methodically, without assumptions, following the evidence to its structural cause. We do not produce tactics. We produce diagnoses.
Organic Growth Diagnostics is a discipline we built from scratch. It did not exist before Growth Forensics named it.
It is not a new way to do SEO. It is not a more comprehensive audit. It is a different type of thing entirely: a structured investigation of an organic growth system designed to find the specific constraint that is preventing the whole engine from working.
We built it because every existing approach to organic growth shares the same structural limitation. SEO agencies, growth consultants, and content programmes all optimise individual components of an organic growth system. None of them diagnose the system as a whole. That gap is why companies invest seriously in organic growth and still cannot explain why it keeps underdelivering.
What makes Growth Forensics unique is its proprietary diagnostic framework
The diagnostic methodology is built on a ten-component framework we developed to model how organic growth systems work and fail. We call it the Organic Growth Engine.
Each component represents a distinct capability that a company needs to grow organically at scale. The components are interdependent: each one depends on the ones before it. When any component is failing, it limits the performance of every component that follows. The failing component is the constraint.
Finding it is the diagnosis.
The output of a Growth Forensics engagement is a digital dossier.
Not a report. Not a slide deck. Not a list of 200 technical issues ranked by some formula. A dossier is a private, persistent digital workspace that contains the full structural diagnosis of your organic growth engine: which components are functioning, which are fragile, which are actively blocking growth, and in what exact sequence the constraints must be addressed.
It is built from your own data. Google Search Console, Google Analytics, your content estate, your technical infrastructure, your brand presence. The findings are grounded in evidence from your systems, not in our opinion about industry best practice.
A founder who has worked with agencies and consultants and still cannot explain why organic is underdelivering has never received a structural diagnosis. That is what the dossier contains.
We highly recommend you take a look at the full framework breakdown and how it could diagnose your company’s organic growth engine health.
Every engagement begins with a diagnostic. The diagnostic is complete and standalone — what comes after it depends on what you need and how much you want Growth Forensics involved in the execution.
All pricing is in USD and scoped per engagement. There are no fixed packages because the diagnostic findings determine what the build requires. Pricing is discussed in the scoping call, after the engine state is understood.
Organic growth engines do not fail randomly. They fail in recognisable patterns: combinations of component failures that produce a specific commercial symptom. Most companies experiencing chronic organic underperformance will recognise themselves in at least one of these.
Agencies and consultants are not the problem. The type of work they are designed to do is the problem.
Every approach to organic growth that exists today starts with a component: fix the technical issues, produce the content, build the links, improve the rankings. These are legitimate activities. But they are all answers to a question that has not been asked yet: which component is actually the constraint?
When you fix the wrong component first, the results are marginal at best and invisible at worst. When you fix the right component, in the right sequence, the results compound. The difference between those two outcomes is not effort or quality of execution. It is whether a diagnosis preceded the intervention.
An SEO audit is typically a technical review of a website — crawl errors, meta data, site speed, indexation issues. It answers the question: are there technical problems preventing the site from ranking? That is a useful question, but it is not the question most companies with an underperforming organic channel need answered.
A Growth Forensics diagnostic starts from a different question: which structural component of the organic growth engine is the binding constraint on commercial performance, and what is the correct sequence for addressing it? Technical accessibility is one of ten components assessed — and in most cases, it is one of the healthiest, because the obvious technical problems have usually been fixed. The constraint is almost never a robots.txt issue.
The practical difference: an SEO audit produces a list of things that could be improved. A diagnostic produces a ranked intervention sequence — the specific order in which to address structural gaps so that each fix compounds the one before it rather than running in parallel with no structural logic.
The most common finding in a Growth Forensics diagnostic is that Category Presence — whether the company exists in the search results buyers use before they know which vendors to evaluate — is the binding constraint. This is rarely identified in a technical audit because it is not a technical problem. It is an architectural one.
If the audit identified the binding constraint in your organic growth engine and produced an intervention sequence that the team has been executing against, and if that work is producing measurable improvement in organic pipeline — then you probably do not need a diagnostic right now.
If the audit produced a list of improvements, some of which have been implemented, and organic pipeline has not materially improved despite organic traffic growing — then the audit did not identify the binding constraint. Implementing fixes to non-binding constraints produces marginal results. The traffic moving in the right direction while the pipeline does not is one of the clearest signals that the diagnosis was incomplete.
The question to ask about any prior audit is: did it tell you which component of the organic growth engine was the constraint, and did it tell you why fixing that constraint first would unlock the components downstream of it? If not, it was a useful technical review — not a structural diagnosis.
The honest answer is: it shares one characteristic with strategy consulting — it produces a document rather than ongoing execution — and is structurally different in every other way.
Strategy consulting typically applies established frameworks to a company’s situation and produces recommendations that reflect those frameworks. Growth Forensics runs a defined signal-level assessment of the organic growth engine and produces findings that are specific to what is actually happening in that engine. Every finding is traceable to a signal. Every recommendation is connected to a measured gap. There is no framework applied from outside — only what the data shows.
The other meaningful difference: the output is designed to be used, not to be presented. The dossier is written for the team who will execute the intervention sequence, not for a board review. It contains specific instructions, specific evidence, and specific success criteria for each recommendation — not observations and strategic implications.
A useful test: after reading a consulting deliverable, does the team know exactly what to do first, and why? The dossier is designed to answer that question without ambiguity.
This question has a more interesting answer than it appears to, and it is worth being direct about it.
The issue is not qualification — it is structural independence and a different diagnostic model. An agency running your organic programme has an inherent interest in the programme continuing. That does not make the agency dishonest; it makes the agency structurally positioned to recommend more of what it already does rather than to identify the constraint that its current approach is not addressing. This is not a criticism of any specific agency. It is how commercial incentives work.
Growth Forensics does not execute the programme being assessed. There is no retainer to protect, no content production quota to defend, and no prior strategic recommendation to validate. The diagnostic is run against a defined methodology — 122 signals across ten components — and the findings go where the data takes them, including findings that may indicate the current agency’s approach is addressing the wrong constraint.
On credentials specifically: the diagnostic model is grounded in over a decade of organic growth work across startups and scaled companies, including five years as SEO lead at Canva. But the more relevant credential is the model itself — the methodology is documented, the signal set is defined, and the findings are evidence-based. You are not buying access to someone’s opinions. You are buying a structured assessment that can be evaluated, challenged, and acted on.
You would not look for a second opinion if you had confidence that the current strategy was producing the commercial outcomes you expected. The fact that you are looking at this suggests that traffic is up, or rankings are improving, or content is being produced — but pipeline is not moving in proportion. That gap is the reason.
An agency that tells you the strategy is solid while organic pipeline underperforms has either not correctly identified the binding constraint, or has identified it but does not have a commercial interest in naming it. Neither is a useful position for the company.
The diagnostic does not replace the agency. In most cases, a well-briefed agency can execute the intervention sequence that the diagnostic produces. The diagnostic tells the agency which problem to solve first — and that changes the work significantly.
Specific enough that the team knows what to do first, why, and roughly how long it will take.
At the signal level, a recommendation will say something like: ‘Redirect the three orphan campaign landing pages identified in the crawl to their most relevant live commercial pages. Two of these pages have 11 combined referring domains that are currently directing authority to dead ends. This is a 20-minute development task. Authority transfer will occur within 2–4 weeks of the redirects being indexed.’ That is the level of specificity throughout.
At the component level, the intervention sequence defines the order in which structural gaps should be addressed — not just what to fix, but why fixing it before the next item on the list produces a compounding result rather than parallel activity with no structural logic.
What the recommendations do not include: exact copy, exact page designs, or execution of the work itself. The dossier is a diagnostic document, not an implementation brief. The line between diagnosis and execution is deliberate — the diagnostic tells the team what to build and in what order. The team, an agency, or a specialist builds it.
The dossier is a structured document covering all ten components of the organic growth engine. For each component, it contains: what was assessed and why, the signal-level findings (each signal assessed individually with a finding and a state — Healthy, Fragile, Blocking, or Missing), the evidence supporting each finding, and the recommendation.
The evidence is concrete — screenshots of specific pages, GSC data exports, crawl data, keyword ranking tables, AI platform test results. Where data does not yet exist, the dossier contains specific instructions for what to produce and how to interpret it.
The dossier also contains two things that sit above the component level: the engine state summary — a one-page view of all ten component states and what the pattern of states indicates about the overall engine — and the intervention sequence, which is the ordered list of actions that will produce compounding improvement rather than parallel activity.
A demo dossier for a fictional company is available on request. It shows exactly what a component assessment looks like at the signal level, including a component where the finding is Blocking, one where it is Healthy, and one where it is Missing. It is the most direct way to evaluate whether the specificity of the output is useful for your situation.
Yes. That is the point of the dossier.
The dossier is written to be used by a competent internal team or a well-briefed agency without further involvement from this practice. The recommendations are specific enough to brief a specialist, the evidence is documented enough to validate the findings independently, and the intervention sequence is clear enough to use as a project brief.
If you commission a diagnostic and then take the dossier to your existing agency and brief them against it, that is a completely valid outcome. If the diagnostic finds that your existing agency’s approach is not addressing the binding constraint, the dossier gives you the evidence to have that conversation and redirect the work.
Build and Retain engagements are available for companies who want Growth Forensics involved in the execution — but they are offered because they produce faster and more predictable results for the interventions that are architecturally complex, not because the dossier is incomplete without them.
Disagreement with a finding is a legitimate outcome and it happens. The dossier review session at the end of the diagnostic exists partly for this reason.
Every finding is supported by specific evidence — the signal data, the crawl data, the GSC export, the AI platform test results. If a finding is disputed, the starting point is the evidence, not the conclusion. If the evidence is solid and the interpretation is disputed, that is a conversation worth having explicitly. If the evidence is incomplete or the interpretation can be shown to be wrong, the finding changes.
What is not available is a finding adjusted to align with the existing strategy. The diagnostic produces findings based on what the data shows. If a finding is uncomfortable because it contradicts a prior decision or the current agency’s recommendation, that discomfort is usually the diagnostic working correctly.
The diagnostic is scoped per engagement. There is no fixed price because there is no fixed engine — the scope depends on the size of the content estate, the complexity of the technical infrastructure, whether multiple markets or audience segments are in scope, and the current state of the measurement and data infrastructure.
The scoping call is the only way to give an accurate number. That is not a commercial tactic — it is structurally true. A diagnostic of a 50-page site with a simple content programme is a different engagement from a diagnostic of a 1,000-page site with international presence and a complex agency relationship.
What can be said before the scoping call: the diagnostic investment is typically in the range where it makes commercial sense for companies spending $3,000 or more per month on organic growth activities — content, agency, or internal resource. If the organic spend is below that, the diagnostic cost will not be proportionate to the potential improvement.
If it is above that, the diagnostic is typically one of the highest-leverage investments available, because it tells you whether the spend is addressing the right constraint.
Four to six weeks from the point data access is provided. The timeline has two phases.
The first phase is data collection and signal assessment — approximately three weeks. This involves the signal-level work across all ten components: the crawl data, the GSC analysis, the keyword research, the AI platform testing, the backlink profile assessment, the conversion data review, and the qualitative assessments of positioning, operating system, and expansion readiness.
The second phase is dossier production and review — approximately one to two weeks. The dossier is written, reviewed internally, and then delivered in a review session where the findings and intervention sequence are walked through in full.
The diagnostic does not slow the current organic programme. The work runs in parallel with whatever the team and agency are already doing. The only demand on your time during the engagement is the data access at the start and the review session at the end.
Four things, all of which can typically be provided in under an hour:
Access to Google Search Console — read access to the property. This is the primary data source for organic performance at the query and page level.
Access to website analytics — read access to Google Analytics 4 or equivalent, with conversion events configured. This is needed for the commercial performance data: session-to-lead rates, pipeline by landing page, engagement by traffic segment.
Access to the Ahrefs or Semrush project if one exists — or confirmation that the diagnostic can run its own keyword and backlink analysis if no existing account is in use.
A 30-minute briefing call at the start of the engagement with the person who owns the organic programme — not necessarily the CEO. This call covers the presenting problem, the current agency and team structure, and any context that is not visible in the data.
No access to the CMS, the website backend, or any confidential commercial data is required. The diagnostic is conducted entirely from organic performance data and publicly accessible signals.
No. And any diagnostic practice that offers this guarantee is making a commitment it cannot keep.
What can be said with confidence: the intervention sequence produced by the diagnostic is the correct order of operations for the specific engine assessed, based on the structural relationship between components. Addressing a Blocking component before addressing Fragile components downstream of it will produce better results than addressing them in the wrong order. This is a structural claim, not a performance guarantee.
What cannot be guaranteed: the speed and magnitude of improvement, which depend on the competitive landscape in the specific category, the quality of execution, the timeline of the interventions, and factors external to the organic engine — market conditions, product changes, pricing shifts.
Having an agency does not make the diagnostic redundant — in most cases, it makes it more useful, because the diagnostic gives you a way to evaluate the agency’s work against the structural needs of the engine rather than against activity metrics.
The most common pattern is: a company has been on a retainer for 12–24 months, content is being produced, some rankings exist, and organic traffic is growing. But organic pipeline is not growing in proportion. The agency’s reporting shows everything moving in the right direction at the activity level. The diagnostic typically reveals that the agency has been addressing the wrong constraint — often because it was not briefed to identify the constraint in the first place.
After the diagnostic, there are three possible outcomes for the agency relationship. The agency is well-positioned to execute the intervention sequence with a revised brief — and the relationship continues with better direction.
The agency does not have the capability to address the specific constraints identified — and the company makes an informed decision about how to supplement or replace it. The agency was doing the right things but in the wrong order — and the intervention sequence reorients the work.
All three outcomes are more useful than continuing without knowing which one applies.
It depends on what ‘early stage’ means in practice.
If the organic programme has been running for less than six months, has fewer than 20 published pages, and has no meaningful GSC data yet, the diagnostic will not produce useful findings — there is not enough engine to assess. The right investment at this stage is building the foundations: technical infrastructure, positioning clarity, and the first commercial pages. Come back when the engine exists.
If the programme has been running for 6–12 months, has 20 or more pages, and has GSC data showing at least some organic impressions and clicks — even if the numbers are small — the diagnostic can identify the structural gaps before they compound. This is actually the most valuable moment for a diagnostic: the constraints are visible but have not yet been reinforced by months of investment in the wrong direction.
The question to ask is not ‘is the programme big enough?’ but ‘have we been investing in organic for long enough that a structural misalignment would have produced a measurable gap between what we expected and what we are seeing?’ If yes, the diagnostic is useful now.
Series A is a legitimate stage for a diagnostic if two conditions are true: organic is planned as a primary acquisition channel at scale, and there is enough of an engine — pages, content, data — to assess structurally.
Where Series A diagnostics are most useful is not in fixing a mature engine but in setting the architecture correctly before significant investment is made. A Series A company that has been operating for 18 months with some organic activity and is about to hire a Head of Marketing or expand its content programme significantly is exactly the right candidate. The diagnostic tells them which structural foundations to build first before scaling the spend.
Where Series A diagnostics are less useful is when the company is pre-revenue or pre-product-market fit, organic is one of several untested channels, and the immediate need is validation of the business model rather than optimisation of an organic growth engine. In that case, the diagnostic will surface structural gaps in an engine that has not yet been given the conditions to function — which produces findings that are technically accurate but commercially premature.
Yes — with one caveat.
The diagnostic can be commissioned by the Head of Marketing, the VP of Growth, the Head of SEO, or any person with the authority to provide data access and the mandate to act on the findings. The practical process — briefing, data access, dossier review — works at any level.
The caveat: the findings will almost certainly have implications for budget, agency relationships, and organisational prioritisation. A dossier that identifies the binding constraint as Category Presence and recommends rebuilding the content strategy around category landing pages rather than informational blog volume is a finding that has resource implications above the organic programme lead’s authority level.
The diagnostic produces its full value when there is someone with the authority to act on structural findings — which in most Series A, B, and C companies means at least one senior stakeholder, usually the CEO or CPO, is aware the diagnostic is happening and prepared to review the findings. The diagnostic does not need to be commissioned by the CEO. But it should not be a surprise to them either.
The opposite is usually true.
A new Head of Marketing arriving without a structural diagnosis of the organic engine will spend their first 60–90 days forming their own view of the engine from the inside.
That view will be shaped by the metrics the current dashboard tracks, the narrative the agency provides, and the institutional assumptions already baked into the team. By month three, they will have a hypothesis about what needs to change — but it will be formed without the signal-level data that the diagnostic produces.
Running the diagnostic in the first four weeks of a new Head of Marketing’s tenure gives them the structural picture before the institutional narrative hardens. They arrive at month three having already diagnosed the engine, with a clear intervention sequence and a shared language for discussing the engine’s health with the leadership team. That is a materially different starting position.
The only exception: if the new Head of Marketing has a strong prior point of view about how the organic engine should be run and is not open to findings that contradict it, the diagnostic will produce friction rather than alignment. But that is a question about the hire, not about the timing of the diagnostic.
